Finance Lucid Capital Initiates Ovid Therapeutics Inc. (OVID) at Buy with $5.50 TargetAugust 24, 20250 Ovid Therapeutics Inc. (NASDAQ:OVID) is among the many finest US shares beneath $10 to spend money on. Analysts at Lucid…
